medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2005, Number 2

<< Back Next >>

Rev Mex Urol 2005; 65 (2)

Radical prostatectomy. Experience at Hospital General “C” ISSSTE. Hermosillo, Sonora

Leos GCA, Serdio SMA, Rodríguez ZMA, Mejía GS, Baltazares LA

Language: Spanish
References: 15
Page: 93-96
PDF size: 46.05 Kb.


ABSTRACT

Introduction. Radical prostatectomy is the chosen treatment in those prostate cancer in begining stages and with posibilities of being cured. Since the inclusion of the PSA (prostatic specific antigen) in the urologist diagnosis arsenal, the posibilities of getting diagnosis in earlier stages has increased considerably. Material and methods. We have the experience of radical prostatectomy in 38 patients operated in the last six years in a small 100 beds province hospital where patients where elegible to obtain the services from the institution, converge from all over state of Sonora. Conclusions. The results, complications and follow-up of the patients are analyzed here. Its about a preliminary report due to the fact that most of the patients who were operated have not covered the sufficient length of time of five years to consider survival.


REFERENCES

  1. Greenle R, Hill Carmon Murria Tet, et al. Cancer statics 2001. Ca Cancer J Clinic 2001; 51: 15-36.

  2. Gronberg Henrik. Prostate cancer epidemiology. Lancet 2003; 361: 859-64.

  3. Metlin C, Murphy G, Ho R, Menck H. The national cancer data base report on longitudinal observations on prostate cancer. Cancer 1996; 7: 2162-6.

  4. Metlin C. Impact of screening on prostate cancer rates and trends. Microsc Res Tech 2000; 51: 415-8.

  5. Imai K, Ichinose Y, Kubota Y, Yamanaka H, Sato J. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer. J Urol 1995; 154: 1085.

  6. Catalona W, Smith D. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term result. J Urol 1998; 160: 2428-34.

  7. Walsh PC, Carmichael M, et al. Pathological and clinical findings with progression to predict tumor extent of non palpable (stage T1c) prostate cancer. JAMA 1994; 271: 368.

  8. Pound C, Partin A, Eisenberger M, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-7.

  9. Neyra G, Rodríguez R. Prostatectomía radical retropúbica en el cáncer localizado de la próstata, seguimiento a largo plazo. Rev Mex Urol 1993; 53: 97-102.

  10. 10.Ohrio M, Wheeler TM, Katan MW, Goto Y. Prognostic significance of positive surgical margins in radical prostatectomy for prostate cancer specimens. J Urol 1995; 154: 1818.

  11. 11.Rodríguez Covarrubias F y cols. Recurrencia bioquímica en pacientes con adenocarcinoma de próstata. Rev Mex Urol 2004; 64: 6-12.

  12. 12.INEGI. Registro histopatológico de neoplasias en México, 1999.

  13. 13.D Amico AV, Whittington R, Malkowics SB, et al. Biochemical outcame after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74.

  14. 14.Epstein JL. Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am 1996; 23(4): 651-63.

  15. 15.Stamey TA, Viller AA. McNeal JE. Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol 1990; 143: 166.




2020     |     www.medigraphic.com